These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12030789)

  • 41. The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients.
    Coleman MD; Rhodes LE; Scott AK; Verbov JL; Friedmann PS; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1992 Sep; 34(3):244-9. PubMed ID: 1389948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuromuscular blocking drug pharmacodynamics after chronic exposure to H2- antagonists.
    Rana J; Ramzan I
    In Vivo; 1995; 9(2):163-6. PubMed ID: 7548793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of histamine 2 receptor antagonists on endothelial-neutrophil adhesion and surface expression of endothelial adhesion molecules induced by high glucose levels.
    Takeuchi Y; Okayama N; Imaeda K; Okouchi M; Omi H; Imai S; Akao M; Takeda Y; Hukutomi T; Itoh M
    J Diabetes Complications; 2007; 21(1):50-5. PubMed ID: 17189874
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sex-dependent sensitivity to dapsone-induced methaemoglobinaemia in the rat.
    Coleman MD; Winn MJ; Breckenridge AM; Park BK
    Biochem Pharmacol; 1990 Feb; 39(4):805-9. PubMed ID: 2306286
    [No Abstract]   [Full Text] [Related]  

  • 45. Dapsone-associated methaemoglobinaemia in patients with a haematologic malignancy.
    Subramaniam A; Corallo C; Nagappan R
    Anaesth Intensive Care; 2010 Nov; 38(6):1070-6. PubMed ID: 21226440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dapsone Hydroxylamine, an Active Metabolite of Dapsone, Can Promote the Procoagulant Activity of Red Blood Cells and Thrombosis.
    Bian Y; Kim K; An GJ; Ngo T; Bae ON; Lim KM; Chung JH
    Toxicol Sci; 2019 Dec; 172(2):435-444. PubMed ID: 31428780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dapsone induced methaemoglobinaemia.
    Landers D; Bergin C; O'Leary A; Merry C; Keating S; Mulcahy F
    Int J STD AIDS; 1996 Oct; 7(6):445-7. PubMed ID: 8940676
    [No Abstract]   [Full Text] [Related]  

  • 48. Disposition of dapsone and monoacetyldapsone in rats.
    Gordon GR; Peters JH; Ghoul DC; Murray JF; Levy L; Biggs JT
    Proc Soc Exp Biol Med; 1975 Nov; 150(2):485-92. PubMed ID: 1208566
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Simultaneous high performance liquid chromatographic determination of dapsone and monoacetyldapsone in human plasma and urine.
    Abuirjeie MA; Irshaid YM; al-Hadidi HF; Rawashdeh NM
    J Clin Pharm Ther; 1991 Aug; 16(4):247-55. PubMed ID: 1939403
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The disposition of dapsone and monoacetyldapsone in the dog (38516).
    Peters JH; Gordon R; Biggs JT; Levy L
    Proc Soc Exp Biol Med; 1975 Jan; 148(1):251-5. PubMed ID: 1129265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dapsone hydroxylamine induces premature removal of human erythrocytes by membrane reorganization and antibody binding.
    Bordin L; Fiore C; Zen F; Coleman MD; Ragazzi E; Clari G
    Br J Pharmacol; 2010 Nov; 161(5):1186-99. PubMed ID: 20662842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-acetylation polymorphism of dapsone in a Japanese population.
    Horai Y; Ishizaki T
    Br J Clin Pharmacol; 1988 Apr; 25(4):487-94. PubMed ID: 3382590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Asymptomatic methaemoglobinaemia and its implications.
    Chawla R; Kundra P; Bhattacharya A
    Acta Anaesthesiol Scand; 1998 Jul; 42(6):736-8. PubMed ID: 9689284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man.
    Coleman MD; Scott AK; Breckenridge AM; Park BK
    Br J Clin Pharmacol; 1990 Nov; 30(5):761-7. PubMed ID: 2271376
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of dapsone poisoning complicated by methaemoglobinaemia.
    Dawson AH; Whyte IM
    Med Toxicol Adverse Drug Exp; 1989; 4(5):387-92. PubMed ID: 2811676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A case of dapsone-induced methaemoglobinaemia.
    Tan YA; Ng KC; Cheo SW; Khoo TT; Low QJ
    Clin Med (Lond); 2020 Sep; 20(5):519-521. PubMed ID: 32934050
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies on dapsone induced haemolytic anaemia. I. Methaemoglobin production and G-6-PD activity in correlation with dapsone dosage.
    Manfredi G; De Panfilis G; Zampetti M; Allegra F
    Br J Dermatol; 1979 Apr; 100(4):427-32. PubMed ID: 454569
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unexplained acute severe methaemoglobinaemia in a young adult.
    Falkenhahn M; Kannan S; O'Kane M
    Br J Anaesth; 2001 Feb; 86(2):278-80. PubMed ID: 11573675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deliberate self-poisoning with dapsone. A case report and summary of relevant pharmacology and treatment.
    Ferguson AJ; Lavery GG
    Anaesthesia; 1997 Apr; 52(4):359-63. PubMed ID: 9135190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dapsone as treatment adjunct in ARDS.
    Kast RE
    Exp Lung Res; 2020; 46(5):157-161. PubMed ID: 32286085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.